Evidence map›Paper›PMID 29146991›Full record

ArticleScientific reports2017

KLF5 promotes cervical cancer proliferation, migration and invasion in a manner partly dependent on TNFRSF11a expression.

Dong Ma, Ling-Ya Chang, Shan Zhao, Jun-Jian Zhao, Yan-Jie Xiong, Fu-Yuan Cao, Lu Yuan, Qi Zhang, Xin-Yue Wang, Mei-Li Geng and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Dong MaSchool of Public Health, North China University of science and technology, Jianshe Road 57, Tangshan, 063000, Hebei, China.
Ling-Ya ChangSchool of Public Health, North China University of science and technology, Jianshe Road 57, Tangshan, 063000, Hebei, China.
Shan ZhaoDepartment of Cancer Second Division, The Second Hospital of Hebei Medical University, 215 Heping West Road, Shijiazhuang, 050000, Hebei, China.
Jun-Jian ZhaoNorth China University of Science and Technology Affiliated Hospital, Jianshe Road 57, Tangshan, 063000, Hebei, China.
Yan-Jie XiongNorth China University of Science and Technology Affiliated Hospital, Jianshe Road 57, Tangshan, 063000, Hebei, China.
Fu-Yuan CaoSchool of Public Health, North China University of science and technology, Jianshe Road 57, Tangshan, 063000, Hebei, China.
Lu YuanSchool of Public Health, North China University of science and technology, Jianshe Road 57, Tangshan, 063000, Hebei, China.
Qi ZhangSchool of Public Health, North China University of science and technology, Jianshe Road 57, Tangshan, 063000, Hebei, China.
Xin-Yue WangSchool of Public Health, North China University of science and technology, Jianshe Road 57, Tangshan, 063000, Hebei, China.
Mei-Li GengDepartment of Obstetrics and Gynecology, Workers' Hospital of Tangshan, Wenhua road 27, Tangshan, 063000, Hebei, China.
Huan-Yu ZhengDepartment of Obstetrics and Gynecology, Workers' Hospital of Tangshan, Wenhua road 27, Tangshan, 063000, Hebei, China.
Ou LiDepartment of Obstetrics and Gynecology, Workers' Hospital of Tangshan, Wenhua road 27, Tangshan, 063000, Hebei, China. tsliou@163.com.
North China University of Science and Technology · CNNorth China University of Science and Technology Affiliated Hospital · CNTangshan People's Hospital · CNLiaoning Provincial People's Hospital · CNSecond Hospital of Hebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the transcription factor Krüppel-like factor 5 (KLF5) plays important roles in both inflammation and cancer, the mechanism by which this factor promotes cervical carcinogenesis remains unclear. In this study, we demonstrated a potential role for tumour necrosis factor receptor superfamily member 11a (TNFRSF11a), the corresponding gene of which is a direct binding target of KLF5, in tumour cell proliferation and invasiveness. Coexpression of KLF5 and TNFRSF11a correlated significantly with tumorigenesis in cervical tissues (P < 0.05) and manipulation of KLF5 expression positively affected TNFRSF11a mRNA and protein expression. Functionally, KLF5 promoted cancer cell proliferation, migration and invasiveness in a manner dependent partly on TNFRSF11a expression. Moreover, in vivo functional TNFRSF11a-knockdown mouse studies revealed suppression of tumorigenicity and liver metastatic potential. Notably, tumour necrosis factor (TNF)-α induced KLF5 expression by activating the p38 signalling pathway and high KLF5 and TNFRSF11a expression increased the risk of death in patients with cervical squamous cell carcinoma. Our results demonstrate that KLF5 and TNFRSF11a promote cervical cancer cell proliferation, migration and invasiveness.

Indexed as

Cell MovementAnimalsCarcinoma, Squamous CellCell Line, TumorCell ProliferationFemaleGene Expression Regulation, NeoplasticHumansKruppel-Like Transcription FactorsMice, SCIDMiddle AgedNeoplasm Invasivenessp38 Mitogen-Activated Protein KinasesPromoter Regions, GeneticProtein BindingReceptor Activator of Nuclear Factor-kappa BKLF5 protein, humanKruppel-Like Transcription Factorsp38 Mitogen-Activated Protein KinasesReceptor Activator of Nuclear Factor-kappa BTNFRSF11A protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID29146991
PMCPMC5691198
OpenAlexW2768013728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.